tiprankstipranks
Advertisement
Advertisement
LENZ Therapeutics trading halted, volatility trading pause
PremiumThe FlyLENZ Therapeutics trading halted, volatility trading pause
2M ago
LENZ Therapeutics trading resumes
Premium
The Fly
LENZ Therapeutics trading resumes
2M ago
Toast downgraded, Lowe’s upgraded: Wall Street’s top analyst calls
Premium
The Fly
Toast downgraded, Lowe’s upgraded: Wall Street’s top analyst calls
2M ago
Lenz Therapeutics Earnings Call Balances Promise and Risk
PremiumCompany AnnouncementsLenz Therapeutics Earnings Call Balances Promise and Risk
2M ago
Closing Bell Movers: Hims  & Hers down 12% on earnings miss
Premium
The Fly
Closing Bell Movers: Hims & Hers down 12% on earnings miss
2M ago
Lenz Therapeutics reports Q1 EPS ($1.32), consensus ($1.07)
Premium
The Fly
Lenz Therapeutics reports Q1 EPS ($1.32), consensus ($1.07)
2M ago
Lenz Therapeutics Earnings Call: High Spend, Growing Traction
PremiumCompany AnnouncementsLenz Therapeutics Earnings Call: High Spend, Growing Traction
4M ago
Lenz Therapeutics price target lowered to $26 from $52 at Citi
Premium
The Fly
Lenz Therapeutics price target lowered to $26 from $52 at Citi
4M ago
Buy Rating on VIZZ Underscored by Improving Prescription Trends and Long-Term Upside Despite Near-Term Revenue Revisions
Premium
Ratings
Buy Rating on VIZZ Underscored by Improving Prescription Trends and Long-Term Upside Despite Near-Term Revenue Revisions
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100